Furthermore, the potential efficacy of tezepelumab should also be explored with regard to its possible therapeutic application in T2-low neutrophilic asthma, given the relevant contribution of TSLP to the pathophysiology of this difficult-to-treat endotype. Here, TSLP is linked to asthma.